German pharmaceutical company BioNTech has agreed to pay a combined sum of more than $1.2 billion to resolve separate disputes over royalty payments related to its COVID-19 vaccine. https://p.dw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback